ClinicalTrials.gg
RecruitingNCT07245862S-FAMEUpdated Apr 30, 2026

Evaluation of a Family-centered Program for Problematic Gaming/Excessive Screen Use

An interventional study of Family-centered Program for Problematic Gaming/Excessive Screen Use in a child and adolescent population within Social Services and Control in Adolescent Behavior, Social Media Addiction and Gaming Disorder, sponsored by Region Skane. Recruiting at 1 site in Sweden. Open to participants aged 11 Years to 14 Years. Per ClinicalTrials.gov, last updated 2026-04-30.

Sponsored by Region Skane · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
170
Allocation
Randomized
Ages
11 Years to 14 Years
Sex
All
01

Study summary

The Family-Centered Program for Problematic Gaming and Excessive Screen Use (FAME) is a pioneering initiative designed to address the growing challenges of excessive screen use and gaming among children and adolescents, particularly within family dynamics.

Read the detailed description

The Family-Centered Program for Problematic Gaming and Excessive Screen Use (FAME) is a pioneering initiative designed to address the growing challenges of excessive screen use and gaming among children and adolescents, particularly within family dynamics. With digital media becoming one of the most prevalent leisure activities, excessive use has been linked to adverse outcomes, including depression, sleep disturbances, and family conflicts. Despite these concerns, there are no evaluated family-centered interventions in Sweden that address these issues comprehensively. This randomized controlled trial (RCT) aims to evaluate the effectiveness and feasibility of the S-FAME program, developed in collaboration with social services across two municipalities (Lund, Eslöv). The program integrates psychoeducation, cognitive restructuring, and social-emotional learning, focusing on both children and their families. It acknowledges that problematic screen use often develops within family contexts and aims to improve parenting practices and enhance parent-child relationships. The project aligns with the new Social Services Act, which will come into effect in July 2025, emphasizing easily accessible, preventive, and low-threshold interventions-so-called non-means-tested services. By targeting both individual and family needs, the intervention has the potential to reduce societal costs, enhance family well-being, and address health inequalities. With its innovative and scalable design, S-FAME provides a much-needed framework to tackle one of today's most pressing challenges in youth development- excessive screen use. We are a team of researchers with great experience in research as well as clinical work in the field of adolescence, social work and ANDTS (Alkohol, narkotika, droger, tobak och spel). The project is well established within the School of Social Sciences/Medical Faculty at Lund University, as well as within the innovation and development departments of two social services units. PI Emma Claesdotter-Knutsson (ECK), associate professor and senior consultant in child and adolescent psychiatry at Lund University/Region Skåne with major research areas of gaming, gambling and screens use. ECK has extensive clinical expertise and has played a key role at the Swedish Public Health Agency, contributing to the development of recommendations on child digital media use. PI ECK brings extensive experience and formal training in leading collaborative projects.

02

Conditions studied

  • Adolescent Behavior
  • Social Media Addiction
  • Gaming Disorder
  • Family Relations
03

In context

Adolescent Behavior

305 studies on the registry are indexed under Adolescent Behavior; 47 are open to participants now.

This study's planned enrollment of 170 is close to the median of 172 across 256 interventional studies indexed under Adolescent Behavior.

Browse Adolescent Behavior studies →

Lead sponsor

Region Skane is the lead sponsor of 386 studies on the registry; 122 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • family conflicts related to screen use
  • spaeks and udnerstand swedish

Exclusion criteria

Exclusion Criteria:

  • se above
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
170 participants (estimated)

Study arms

  • Active comparator
    Intervention

    The critical components include psychoeducation, cognitive restructuring, and social and emotional learning. The goals are to help children and parents understand the positive and negative aspects of screen use and to prevent related problems and family conflicts. The intervention consist of 4 group mettings parents and children separate. Max 10 children per group

    Behavioral: Family-centered Program for Problematic Gaming/Excessive Screen Use in a child and adolescent population within Social Services

  • Active comparator
    Control

    This group will recieve treatment as usual. After final follow up this group will be offered an online parental intervention of 3 sessions

    Behavioral: Control

Interventions

  • BehavioralFamily-centered Program for Problematic Gaming/Excessive Screen Use in a child and adolescent population within Social Services

    The critical components include psychoeducation, cognitive restructuring, and social and emotional learning.his would be the first intervention offering help for both children and their parents. Such an intervention could be beneficial not only to individual families, but also to society at large by reducing societal costs, enhancing family well-being, and addressing health inequalities . the intervention is agroup intervention in 4 sessions with parents in one group and children in one group. The goals are to help children and parents understand the positive and negative aspects of screen use and to prevent related problems and family conflicts. T

  • BehavioralControl

    This group will recieve TAU == treat ment as usual depending on the practice at the Social service they belong to

06

What researchers measure

Primary outcomes

  1. FCU

    five items measure parent-child warmth, and three items measure parent-child conflicts

    Time frame: Baseline; Post treatment; 1 month post treatment

Secondary outcomes

  1. SCREENS-Q (adapted) time (19) • PARCA for assessing aspects of parent-child relationship and parenting practices (22) • FCU five items measure parent-child warmth, and three items measure parent-child conflicts (23)

    screening form, for valuing children and adolescent´s screen time screening form, for valuing children and adolescent´s screen time screening form, for valuing children and adolescent´s screen time

    Time frame: Baseline; Post treatment; 1 month post treatment

  2. PARCA

    for assessing aspects of parent-child relationship and parenting practices

    Time frame: Baseline; Post treatment; 1 month post treatment

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Jan 2027, 12 months after the start.

Of 195 non-industry interventional studies with no phase under Adolescent Behavior, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 43. This study's planned 12 months is below that.

Counting every sponsor, half of 198 studies reached it within 20 months; a quarter within 8 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 12, 2025
First posted
Nov 24, 2025
StartActual
Jan 1, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Jan 1, 2028
Last update
Apr 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07245862
Lead sponsor
Region Skane
Collaborators
Lund University
Responsible party
Sponsor
First posted
Nov 24, 2025
Start date
Jan 1, 2026
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 1, 2028 (estimated)
Last update
Apr 30, 2026

Study contacts

Emma Claesdotter-Knutsson, PhD
Contact
emma.claesdotter-knutsson@skane.se
+46768871765
Sabina Kapetanovic, PhD
Contact
sabina.kapetanovic@hv.se

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion